Steven Cohen’s Standard BioTools LAB Stock Holding History
Bought
Maintained
Sold
Other funds holding LAB
LFCM
Steven Cohen's LAB Position: Q3 2026 in Review
Steven Cohen reduced its Standard BioTools (LAB) stake by 85% in Q3 2026, selling an estimated $464K and leaving 104,678 shares worth $77.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3698.
Steven Cohen first reported a position in LAB in Q2 2015 and has held it in 8 quarters since. The position peaked at $1.6M in Q2 2020. 104 funds tracked by Wall St. Rank hold LAB as of Q3 2026.
- Steven Cohen held 104,678 shares of Standard BioTools worth $77.5K as of Q3 2026.
- Steven Cohen sold 603,313 Standard BioTools shares in Q3 2026, an estimated $464K.
- Standard BioTools made up ﹤0.01% of Steven Cohen's portfolio in Q3 2026, its #3698 holding.
- Steven Cohen first reported a position in Standard BioTools in Q2 2015 and has held it in 8 quarters since.
- Steven Cohen's Standard BioTools position peaked at $1.6M in Q2 2020.
- 104 funds tracked by Wall St. Rank held Standard BioTools as of Q3 2026.
Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.